Paragon 28 rises on higher 2022 sales forecast
** Paragon 28 Inc's shares FNA.N rise 9.8% to $19.8
** Medical device maker raises 2022 sales forecast to $179.5
mln from $176 mln earlier
** Reports Q3 revenue up 28% to $46 mln
** Including session gains, stock had risen ~12% YTD
(Reporting by Khushi Mandowara)
((Khushi.Mandowara@thomsonreuters.com;))
Recent news on Paragon 28
See all newsBrief: SA's Competition Commission Approves Proposed Deal Of Zimmer Biomet & Paragon 28, With Conditions
U.S. RESEARCH ROUNDUP-Estée Lauder, IBM, Meta
Deals of the day-Mergers and acquisitions
U.S. STOCKS ON THE MOVE-Signing Day Sports, Merchants Bancorp, Stride
U.S. STOCKS ON THE MOVE-89Bio, Brinker, Apple